-

ERN eUROGEN Project Review: Positive Assessment
25 August 2026ERN eUROGEN has successfully passed a Project Review of its current four-year Direct Operational Grant (2023-2027), which supports the...
0 -

Cross-ERN Publication: Crisis Preparedness for Rare Disease Patients
25 August 2026A new ‘Viewpoint’ published in The Lancet Regional Health – Europe looks at how the 24 European Reference Networks...
-

Transition Guidelines for Rare Uro-Recto-Genital Conditions
29 July 2026ERN eUROGEN has published Transition Care for Individuals with Rare Uro-Recto-Genital Conditions: A Lifelong, Patient-Centered Approach, a new guidance...
-

ERN eUROGEN: Rare Barometer Mental Health Survey Results
22 July 2026Between September and December 2025, 117 people living with rare and complex uro-recto-genital conditions, from 22 European countries, took...
-

The Next EU Budget and Future ERN Funding
22 July 2026Negotiations for the next long-term European Union (EU) budget, the 2028–2034 Multiannual Financial Framework (MFF), are now in a...
-

ERN eUROGEN at the ESPU: Registry Growth & Research Connections
25 June 2026From Wednesday 17 to Saturday 20 June 2026, the 36th European Society for Paediatric Urology (ESPU) Congress took place...
-

ERN eUROGEN at the 1st UEMS Congress: Highlighting Rare Diseases
25 June 2026On Saturday, 30 May 2026, the first Congress of the European Union of Medical Specialists (UEMS) took place in...
-

Introducing VACTERL Visionaries: A New Support Website
15 June 2026VACTERL Visionaries is a new UK-based resource created by adults living with VACTERL Association, for adults living with VACTERL Association...
-

Five years of CureforU: Global Collaboration on Rare Paediatrics
15 June 2026June 2026 marks five years since CureforU (a global monthly case discussion platform for rare and complex paediatric colorectal...
-

EC Visit to Radboudumc: Showcasing ERN Excellence & Collaboration
28 May 2026In May 2026, ERN eUROGEN (rare uro-recto-genital diseases and complex conditions) and ERN GENTURIS (rare genetic tumour risk syndromes)...
